Filing Details

Accession Number:
0001415889-25-018822
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-07-01 20:32:14
Reporting Period:
2025-06-27
Filing Date:
2025-07-01
Accepted Time:
2025-07-01 20:32:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1689375 Entrada Therapeutics Inc. TRDA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219014 M Scott Rocklage C/O 5Am Venture Management, Llc
4 Embarcadero Center, Suite 3110
San Francisco CA 94111
No No Yes No
1598549 J. Andrew Schwab C/O 5Am Venture Management, Llc
4 Embarcadero Center, Suite 3110
San Francisco CA 94111
No No Yes No
1674324 5Am Ventures V, L.p. C/O 5Am Venture Management, Llc
4 Embarcadero Center, Suite 3110
San Francisco CA 94111
No No No No
1753000 5Am Opportunities I, L.p. C/O 5Am Venture Management, Llc
4 Embarcadero Center, Suite 3110
San Francisco CA 94111
No No Yes No
1790778 5Am Opportunities I (Gp), Llc C/O 5Am Venture Management, Llc
4 Embarcadero Center, Suite 3110
San Francisco CA 94111
No No Yes No
1791889 5Am Partners V, Llc C/O 5Am Venture Management, Llc
4 Embarcadero Center, Suite 3110
San Francisco CA 94111
No No Yes No
Transaction Summary
Sold: 125,000 shares Avg. Price: $6.93 Total Value: $866,632.50
Number of Shares After Transactions: 1,100,248 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-06-27 55,735 $6.91 3,220,287 No 4 S Direct
Common Stock Disposition 2025-06-27 19,265 $6.91 1,113,092 No 4 S Indirect By 5AM Opportunities I, L.P.
Common Stock Disposition 2025-06-30 18,578 $6.81 3,201,709 No 4 S Direct
Common Stock Disposition 2025-06-30 6,422 $6.81 1,106,670 No 4 S Indirect By 5AM Opportunities I, L.P.
Common Stock Disposition 2025-07-01 18,578 $7.12 3,183,131 No 4 S Direct
Common Stock Disposition 2025-07-01 6,422 $7.12 1,100,248 No 4 S Indirect By 5AM Opportunities I, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By 5AM Opportunities I, L.P.
No 4 S Direct
No 4 S Indirect By 5AM Opportunities I, L.P.
No 4 S Direct
No 4 S Indirect By 5AM Opportunities I, L.P.
Footnotes
  1. Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports.
  2. Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports.